Boston Scientific Corporation: Coronary Artery Disease trials

The registry lists 47 Coronary Artery Disease studies with Boston Scientific Corporation as lead sponsor. 0 are open to participants now and 25 have results posted.

Phase 2 3Phase 3 17Phase 4 4No phase 25(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Vortex - Temporary Percutaneous, Transvalvular Circulatory Support System Feasibility StudyCompletedNCT04674111Not applicableResults posted
• Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)CompletedNCT04058990Not applicableResults posted
• A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)CompletedNCT03350542Phase 3Results posted
• PROMUS PREMIER™ China Post-Approval StudyCompletedNCT03273023Results posted
• EVOLVE Short DAPT StudyCompletedNCT02605447Phase 4Results posted
• PLATINUM DiversityCompletedNCT02240810Results posted
• PE PREMIER CHINA CLINICAL TRIALCompletedNCT02230254Not applicableResults posted
• The EVOLVE China Clinical TrialCompletedNCT01966159Not applicableResults posted
• NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary LesionsCompletedNCT01703000Not applicableResults posted
• The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)CompletedNCT01665053Phase 3Results posted
• Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation CatheterCompletedNCT01635881Phase 3Results posted
• PROMUS Element Plus US Post-Approval StudyCompletedNCT01589978Phase 4Results posted
• PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)CompletedNCT01510327Phase 3Results posted
• The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)CompletedNCT01500434Phase 3Results posted
• The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small VesselsCompletedNCT01498692Not applicableResults posted
• ION US Post-Approval StudyCompletedNCT01422889Results posted
• The OMEGA Clinical TrialCompletedNCT01419171Not applicableResults posted
• Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ StentCompletedNCT01285999Not applicableResults posted
• PROMUS Element Japan Small Vessel TrialCompletedNCT01080261Phase 3Results posted
• TAXUS Libertē Post Approval StudyCompletedNCT00997503Results posted
• A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)CompletedNCT00824434Phase 3Results posted
• The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery LesionsCompletedNCT00823212Phase 3Results posted
• TAXUS PERSEUS Small VesselCompletedNCT00489541Phase 3Results posted
• TAXUS PERSEUS WorkhorseCompletedNCT00484315Phase 3Results posted
• SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed ArteriesStatus unknownNCT00114972Phase 3Results posted
• A U.S Post Approval Study Evaluating the SYNERGY XLV (MEGATRON) Stent SystemCompletedNCT04807439
• Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)WithdrawnNCT04059536
• A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)CompletedNCT03875651
• FAST Feasibility StudyCompletedNCT02470884Not applicable
• Post-Approval Study of PROMUS Element™ in ChinaCompletedNCT01677585
• TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study (TE-Prove)CompletedNCT01242696
• PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance StudyCompletedNCT01148329
• Non-inferiority Trial to Assess the Safety and Performance of the Evolution Coronary StentCompletedNCT01135225Not applicable
• CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) StudyCompletedNCT00801710Not applicable
• The Optical Coherence Tomography Drug Eluting Stent InvestigationCompletedNCT00776204Not applicable
• JACTAX LD Drug Eluting Stent TrialCompletedNCT00754975Not applicable
• "JACTAX" Trial Drug Eluting Stent TrialCompletedNCT00754728Not applicable
• TAXUS ARRIVE: TAXUS Peri-Approval Registry: A Multi-Center Safety Surveillance ProgramCompletedNCT00569491Phase 4
• A Study of the TAXUS Liberté Stent for the Treatment of de Novo Coronary Artery Lesions in Small VesselsCompletedNCT00371748Phase 3
• TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery LesionsCompletedNCT00371709Phase 3
• A Study of the TAXUS Liberté Stent for the Treatment of Long De Novo Coronary Artery LesionsCompletedNCT00371475Phase 3
• Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery LesionsCompletedNCT00371423Phase 3
• TC-WYRE: TAXUS Express Stent vs. Cypher Stent - What's Your Real Life Experience?CompletedNCT00344630Not applicable
• A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary StentCompletedNCT00299026Phase 2
• A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer LesionsCompletedNCT00297804Phase 2/3
• TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting StentCompletedNCT00292474Phase 2/3
• VENEK: Healing in Different Vein Harvesting Methods During Aortocoronary Coronary Artery Bypass Graft Surgery (CABG)TerminatedNCT00180388Phase 4